Mission
Our mission is to create a nexus of organizations pushing the envelope in the field of CRISPR-Cas9 gene editing for personalized, cost effective treatment of cancer and place them under the same umbrella where OpenCure can operate as a non-profit with secure recurring donations from the companies we benefit to cover the extraordinary expenses involved in training a common machine learning model to benefit them all.
We will achieve this mission through a common deal structure that allows these organizations to privately share research data with OpenCure. We have an unwavering commitment to preserving the competitive privacy of this data so these organizations remain competitive in the open market through their trade secrets. Our commitment extends to never sharing model weights or our training corpus with the public or other members of the OpenCure Coalition, while still providing a robust, publicly available API of our core product: CPT-9.
Our unique donation structure allows for higher rate limits for organizations above certain revenue & contribution thresholds ensuring that the needs of each organization are met with growth taken into account.